Invention Grant
- Patent Title: Substituted 6,5-fused bicyclic heteroaryl compounds
-
Application No.: US14774937Application Date: 2014-03-14
-
Publication No.: US09776996B2Publication Date: 2017-10-03
- Inventor: John Emmerson Campbell , Kevin Wayne Kuntz
- Applicant: Epizyme, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Epizyme, Inc.
- Current Assignee: Epizyme, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Cooley LLP
- Agent Heidi A. Erlacher
- International Application: PCT/US2014/029285 WO 20140314
- International Announcement: WO2014/144747 WO 20140918
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/437 ; C07D471/04 ; C07D231/56
Abstract:
The present invention relates to azole bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.
Public/Granted literature
- US20160024081A1 Substituted 6,5-Fused Bicyclic Heteroaryl Compounds Public/Granted day:2016-01-28
Information query
